NeuroOne to Present at Planet MicroCap Las Vegas 2026 Conference

NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a medical technology company focused on improving surgical care for neurological disorders, announced today that it will participate in the Planet MicroCap Las Vegas 2026 Conference on June 17-18, 2026. Dave Rosa, President and Chief Executive Officer, will attend the conference in Las Vegas, NV, and is scheduled to deliver a company presentation on Wednesday, June 17, 2026, at 12:00 p.m. Pacific Time in TRACK 6 - Raphael 3.

During the presentation, Mr. Rosa will provide commercialization updates and anticipated milestones for the OneRF platform, which is designed for treatment of the brain, pain, and advanced drug delivery. The company also noted that Mr. Rosa participated in a CEO interview with Planet MicroCap host Robert Kraft ahead of the conference, which can be viewed here.

The conference provides an opportunity for NeuroOne to engage with institutional investors through one-on-one meetings. The company's presentation will be webcast and can be accessed via the conference website. NeuroOne markets a minimally invasive and high-definition electrode technology platform with four FDA-cleared product families: Evo Cortical Electrodes, Evo sEEG Electrodes, OneRF Ablation System for the brain, and OneRF Trigeminal Nerve Ablation System. These solutions aim to reduce hospitalizations and surgical procedures while improving patient outcomes.

For more information on the Planet MicroCap Las Vegas 2026 Conference, or to schedule a meeting with management, interested parties may contact the conference representative or email [email protected]. The company is also engaged in research and development for drug delivery, basivertebral nerve ablation, and spinal cord stimulation programs.